日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma

自动化淋巴结和结外侵犯评估可改善口咽癌的风险分层

Ye, Zezhong; Mojahed-Yazdi, Reza; Zapaishchykova, Anna; Tak, Divyanshu; Mahootiha, Maryam; Pardo, Juan Carlos Climent; Zielke, John; Zha, Yining; Guthier, Christian; Tishler, Roy B; Margalit, Danielle N; Schoenfeld, Jonathan D; Haddad, Robert I; Uppaluri, Ravindra; Haibe-Kains, Benjamin; Fuller, Clifton D; Naser, Mohamed; Burtness, Barbara A; Aerts, Hugo J W L; Hoebers, Frank; Kann, Benjamin H

Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma

艾拉格鲁西布(一种糖原合成酶激酶3β抑制剂)联合化疗(可联合或不联合免疫疗法)用于治疗复发性、转移性唾液腺癌患者

Hanna, Glenn J; Scarfo, Nicole; Shin, Kee-Young; O'Neill, Anne; Bedard, Veronica; Dennis, Michael J; Sehgal, Kartik; Jo, Vickie Y; Wong, Kristine; Ugolkov, Andrey; Mazar, Andrew; Haddad, Robert I

INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

INDUCE-3:一项随机 II/III 期研究,评估一线 Feladilimab 联合 Pembrolizumab 治疗复发/转移性头颈部鳞状细胞癌患者的疗效

Rischin, Danny; Hansen, Aaron R; Cohen, Ezra E W; Tahara, Makoto; Harrington, Kevin J; Haddad, Robert I; Licitra, Lisa; Mehanna, Hisham; Ferris, Robert L; Koralewski, Piotr; Penkov, Konstantin; Schenker, Michael; Spigel, David R; Daste, Amaury; Hong, Min Hee; Guo, Ye; Chisamore, Michael J; Washburn, Michael L; Phillips-Jones, Amy; Russell, John; Roy-Ghanta, Sumita; Ellis, Catherine; Ballas, Marc; Le Tourneau, Christophe

Impact of segmental location, fibrosis, and emphysema on predicting volume loss during lung resection

肺段位置、纤维化和肺气肿对预测肺切除术中肺容量损失的影响

Cavalieri, Stefano; De Cecco, Loris; Monzani, Dario; Mehanna, Hisham; Ferrarotto, Renata; Simon, Christian; Haddad, Robert; Saintigny, Pierre; Le Tourneau, Christophe; Licitra, Lisa; Croft, Zoey A; Thomas, Griffin; Keister, Evan; McDermott, Maille; Syed, Shoaib; Latzman, Samuel; Wong, Tamika; Serulle, Yafell; Langer, David J; D'Amico, Randy; Boockvar, John; Kumeda, Hirotaka; Eguchi, Takashi; Takeda, Tetsu; Shimura, Masatoshi; Tanaka, Shunnosuke; Yamanaka, Miwa; Nakamura, Daisuke; Matsuoka, Shunichiro; Miura, Kentaro; Hamanaka, Kazutoshi; Shimizu, Kimihiro

Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial

帕博利珠单抗联合立体定向放射治疗治疗程序性细胞死亡蛋白1抑制剂难治性复发或转移性头颈部鳞状细胞癌:一项II期试验

So, Jonathan; Droznin, Alexander D; Tiwari, Payal; Chen, Yu-Hui; Chau, Nicole G; Margalit, Danielle N; Tishler, Roy B; Hanna, Glenn J; Mak, Raymond H; Fitzgerald, Kelly J; Sehgal, Kartik; Li, Shuqiang; Gunasti, Lauren; Kim, Emily; Minken, Jacqueline; Baginska, Joanna; Nau, Allison; Diaz, Ilana Gomez; Shim, Bohoon; Janes, John Thomas 3rd; Uppaluri, Ravindra; Haddad, Robert I; Livak, Kenneth J; Schoenfeld, Jonathan D

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

阿特珠单抗治疗高危局部晚期头颈部鳞状细胞癌:一项随机临床试验

Haddad, Robert; Fayette, Jérôme; Teixeira, Maria; Prabhash, Kumar; Mesia, Ricard; Kawecki, Andrzej; Dechaphunkul, Arunee; Dinis, José; Guo, Ye; Masuda, Muneyuki; Hsieh, Ching-Yun; Ghi, Maria Grazia; Vaz de Melo Sette, Claudia; Harrington, Kevin; Tahara, Makoto; Saba, Nabil F; Lau, Agnes; Jiang, Tao; Yan, Yibing; Ballinger, Marcus; Kaul, Monika; Matheny, Christina; Cuchelkar, Vaikunth; Wong, Deborah J

Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study

在无法切除的局部晚期头颈部鳞状细胞癌中,Xevinapant 或安慰剂联合铂类化疗放疗的疗效比较(TrilynX):一项随机、III 期研究

Bourhis, Jean; Licitra, Lisa F; Burtness, Barbara; Psyrri, Amanda; Haddad, Robert; Harrington, Kevin; Cohen, Ezra E W; Tao, Yungan; Tiscoski, Katsuki Arima; Matitashvili, Amiran; Tahara, Makoto; Sukari, Ammar; Rutkowski, Tomasz; Salas, Sebastien; Nauwelaerts, Heidi; Scheerlinck, Rudi; Ha, Ngoc-Thuy; Schroeder, Andreas; Rodriguez-Gutierrez, Almudena; Schoenfeld, Jonathan D

Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallenge.

表观遗传疗法可使对PD-1抗体耐药的头颈癌对免疫疗法再次治疗敏感

Qin Tingting, Mattox Austin K, Campbell Jean S, Park Jong Chul, Shin Kee-Young, Li Shiting, Sadow Peter M, Faquin William C, Micevic Goran, Daniels Andrew J, Haddad Robert, Garris Christopher S, Pittet Mikael J, Mempel Thorsten R, ONeill Anne, Sartor Maureen A, Pai Sara I

Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors

STING激动剂E7766治疗晚期实体瘤的I期剂量递增和药效学研究

Luke, Jason J; Pinato, David J; Juric, Dejan; LoRusso, Patricia; Hosein, Peter J; Desai, Anupam M; Haddad, Robert; de Miguel, María; Cervantes, Andrés; Kim, Won Seog; Marabelle, Aurélien; Zhang, Yan; Rong, Yuanxin; Yuan, Xiaobin; Champiat, Stéphane

Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes

复发/转移性头颈部鳞状细胞癌的突变图谱及其与免疫检查点抑制剂疗效的关系

McCoon, Patricia; Wang, Ying; Lai, Zhongwu; Zhang, Qu; Li, Weimin; Wildsmith, Sophie; Morsli, Nassim; Raja, Rajiv; Holoweckyj, Nicholas; Walker, Jill; de Los Reyes, Melissa; Mesía, Ricard; Licitra, Lisa; Ferris, Robert L; Fayette, Jérôme; Zandberg, Dan P; Siu, Lillian L; Haddad, Robert